Biora Therapeutics Progresses Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

January 2, 2024

https://www.globenewswire.com/news-release/2024/01/02/2802633/0/en/Biora-Therapeutics-Progresses-Research-Collaboration-for-the-BioJet-Systemic-Oral-Delivery-Platform.html

SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that its BioJet™ Systemic Oral Delivery Platform has met key performance milestones as part of its research collaboration with AstraZeneca. The BioJet platform is designed to use needle-free, liquid jet injection to deliver drug into the small intestine for systemic absorption.

Read more at globenewswire.com

Related news for (BIOR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.